Company Filing History:
4 out of 1,213 
1 out of 8,405 
Years Active: 2023-2026
Title: David Weinstock: Innovator in Cancer Research
Introduction
David Weinstock is a prominent inventor based in Jamaica Plain, MA (US). He has made significant contributions to the field of cancer research, particularly through his innovative work on Janus kinase inhibitors. His research focuses on developing compounds that can potentially treat proliferative diseases.
Latest Patents
David Weinstock holds a patent for "Benzothiazole derivatives and 7-aza-benzothiazole derivatives as Janus kinase 2 inhibitors and uses thereof." This patent includes compounds of Formula (I), along with pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, and prodrugs. The compounds are designed to inhibit Janus kinase 2 (JAK2), which plays a crucial role in various diseases. The patent also outlines pharmaceutical compositions and kits that incorporate these compounds, as well as methods for their use in treating diseases.
Career Highlights
David Weinstock is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to advance his research in oncology. His work has been instrumental in developing new therapeutic strategies for cancer treatment. He has a strong focus on the molecular mechanisms underlying cancer progression and treatment resistance.
Collaborations
David has collaborated with notable researchers in the field, including Nathanael S Gray and Tinghu Zhang. These collaborations have enhanced the scope and impact of his research, leading to innovative approaches in cancer therapy.
Conclusion
David Weinstock is a key figure in the development of novel cancer treatments through his innovative research on Janus kinase inhibitors. His contributions to the field are paving the way for new therapeutic options for patients in need.